Photographic detection of retinopathy in insulin-treated diabetes

Acta Ophthalmologica Scandinavica

Volumn 75, Issue 4, 1997, Pages 447-456

  Kuiv, Reet ^a   Tein, Pille ^a   Algvere, Peep V ^b   Bäcklund, Lars B ^b,d   Holm, Olle ^c  

^a UNIVERSITY OF TARTU   (Estonia)

^b ST ERIK S EYE HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Sabbatsberg Hospital   (Sweden)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Estonia; Hemoglobin A, glycosylated; Photography; Prevalence; Registries

Indexed keywords

CYSTEINE; GLUCOSE; HEMOGLOBIN A1C; TROPICAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CAPILLARY BLOOD; DIABETIC RETINOPATHY; DISEASE SEVERITY; ESTONIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ION EXCHANGE CHROMATOGRAPHY; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OPHTHALMOSCOPY; PHOTOGRAPHY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; VITREOUS HEMORRHAGE;

EID: 0030817330     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1997.tb00412.x     Document Type: Article

References (63)

1. Abourizk NN (1996): Dialogue between clinicians and researchers will lead to a better diabetes classification. Diabetes Care 19: 270-271.
2. Agardh C-D & Berne C (1996): Diabetes hos vuxna. Kunskapsunderlag för vårdprogram. Stockholm, Socialstyrelsen, March 1996: 10.
3. Agardh C-D, Eckert B & Agardh E (1992): Irreversible progression of severe retinopathy in young type 1 insulin-dependent diabetes mellitus patients after improved control. J Diabetes Complications 6: 96-100.
4. Agardh E, Agardh C-D & Hansson-Lundblad C (1993): The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diab Med 10: 555-559.
5. Aldington SJ, Kohner EM, Meuer S, Klein R & Sjølie AK (1995): Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38: 437-444.
6. Anonymous [Stephenson J & Fuller JH] (1994): Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37: 278-285.
7. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44: 968-983.
8. Arnqvist HJ, Littorin B, Nyström L, Scherstén B, Östman J, Blohmé G, Lithner F & Wibell L (1993): Difficulties in classifying diabetes at presentation in the young adult. Diab Med 10: 606-613.
9. Bäcklund LB, Algvere PV & Rosenqvist U (1993): Fotografering av ögonbotten. Bra screeningmetod för diabetesretinopati. Läkartidningen 90: 4453-4457.
10. Bäcklund LB, Algvere PV & Rosenqvist U (1995): Performing diabetic retinopathy screening and measuring the incidence of blindness in an urban region. Giorn It Diab 15 (Suppl): 44-46.
11. Cheng H (1975): Multicentre trial of xenonarc photocoagulation in the treatment of diabetic retinopathy. A randomized controlled study. Interim report. Trans Ophthalmol Soc UK 95: 351-357.
12. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L & Aagenaes O & Aker Diabetes Group (1986): Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: The Oslo Study. Br Med J 293: 1995-1999.
13. Danielsen R, Jónasson F & Helgason T (1982): Prevalence of retinopathy and proteinuria in Type 1 diabetics in Iceland. Acta Med Scand 212: 277-280.
14. Early Treatment Diabetic Retinopathy Study Research Group (1985): Photocoagulation for diabetic macular edema. ETDRS Report Number 1. Arch Ophthalmol 193: 1796-1806.
15. Early Treatment Diabetic Retinopathy Study Research Group (1991): Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS Report Number 10. Ophthalmology 98: 786-806.
16. European Association for the Study of Diabetes Study Group on Eye Complications (1995): 4th Meeting, Turin, 25-26 September 1994. Giorn It Diab 15 (Suppl).
17. European IDDM Policy Group (1993): Consensus guidelines for the management of insulin-dependent (Type 1) diabetes. Diab Med 10: 990-1005.
18. Funatsu H, Yamashita H, Ohashi Y & Ishigaki T (1992): Effect of rapid glycemic control on progression of diabetic retinopathy. Jpn J Ophthalmol 36: 356-367.
19. Gardner MJ & Altman DG, eds (1989): Statistics with Confidence. London, BMJ.
20. Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark Å & Sundkvist G (1993): Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16: 902-910.
21. Groop L, Bottazzo G & Doniach D (1986): Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35: 237-241.
22. Gugliucci A & Bendayan M (1996): Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39: 149-160.
23. Harris MI & Robbins DC (1994): Prevalence of adult-onset IDDM in the U.S. population. Diabetes Care 17: 1337-1340.
24. Henricsson M, Janzon L & Groop L (1995): Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM. Diabetes Care 18: 1571-1576.
25. 1c by a new liquid chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32: 1867-1872.
26. 1c by ion exchange chromatography. Diabetes Care 19: 142-145.
27. Jerneld B & Algvere P (1984): The prevalence of retinopathy in insulin-dependent juvenile-onset diabetes mellitus - a fluorescein-angiographic study. Acta Ophthalmol (Copenh) 62: 617-630.
28. Jerneld B (1988): Prevalence of diabetic retinopathy. Acta Ophthalmol (Copenh) 188 (Suppl): 3-32.
29. Kalits I & Podar T (1990): Incidence and prevalence of type 1 (insulin-dependent) diabetes in Estonia in 1988. Diabetologia 33: 346-349.
30. Kalits I & Podar T (1995): Incidence of IDDM in native Estonians and immigrants to Estonia. Diabetologia 38 (Supplement 1): A174.
31. Keen H (1984): Normoglycaemic re-entry and diabetic complications. Diabetic Med 1: 85-87.
32. Kinyoun JL, Martin DC, Fujimoto WY & Leonetti DL (1992): Ophthalmoscopy versus fundus photography for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci 33: 1888-1893.
33. Klein R, Klein BEK, Moss SE, Davis MD & DeMets DL (1984): The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526.
34. Klein R, Klein BEK, Moss SE & DeMets DL (1986): The validity of a survey question to study diabetic retinopathy. Am J Epidemiol 124: 104-110.
35. Klein R, Klein BE & Moss SE (1989): The Wisconsin Epidemiological Study of Diabetic Retinopathy: a review. Diabetes Metab Rev 5: 559-570.
36. Klein R, Klein BEK, Moss SE & Cruickshanks KJ (1994): The relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Int Med 154: 2169-2178.
37. Klein R (1995): Hyperglycemia and microvascular and macrovascular disease in diabetes. Kelly West lecture, 1994. Diabetes Care 18: 258-268.
38. Klein R & Klein BEK (1995): Vision disorders in diabetes, In: Harris MI (ed). Diabetes in America, 2nd Ed 293-338. NIH Publication No. 95-1468
39. Knuiman MW, Welborn TA, McCann VJ, Stanton KG & Constable IJ (1986): Prevalence of diabetic complications in relation to risk factors. Diabetes 35: 1332-1339.
40. Kostraba JN, Klein R, Dorman JS, Becker DJ, Drash AL, Maser RE & Orchard TJ (1991): The Epidemiology of Diabetes Complications Study IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 133: 381-389.
41. Kristinsson JK, Stefánsson E, Jónasson F, Gíslason I & Björnsson S (1994): Systematic screening for diabetic eye disease in insulin dependent diabetes. Acta Ophthalmol (Copenh) 72: 72-78.
42. Kullberg CE, Bergström A, Dinesen B, Larsson L, Little RR, Goldstein DE & Arnqvist HJ (1996): Comparisons of studies on diabetic complications hampered by differences in GHb measurements. Diabetes Care 19: 726-729.
43. Lloyd CD, Orchard TJ & Klein R (1995): The progression and incidence of retinopathy over two years: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. J Diabetes Complications 9: 140-148.
44. McLeod BK, Thompson JR & Rosenthal AR (1988): The prevalence of retinopathy in the insulin-requiring diabetic patients of an English county town. Eye 2: 424-430.
45. Moloney JBM & Drury MI (1982): The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 93: 745-756.
46. Moskalets E, Galstyan G, Starostina E, Antsiferov M & Chantelau E (1994): Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diabetes Complications 8: 45-50.
47. Nielsen N V (1984): Diabetic retinopathy. I. The course of retinopathy in insulin-treated diabetics. A one-year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol (Copenh) 62: 256-265.
48. Niskanen L, Karjalainen J, Siitonen O & Uusitupa M (1994): Metabolic evaluation of type 2 diabetes: a 10-year follow-up from the time of diagnosis. J Int Med 236: 263-270.
49. Olk RJ & Lee CM (1993): Diabetic Retinopathy. Practical Management. J B Lippincott, New York.
50. Orchard TJ, Dorman JS & Maser RE (1990): Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39: 1116-1124.
51. Patel V, Rassam S, Newsom R, Wiek J & Kohner E (1992): Retinal blood flow in diabetic retinopathy. BMJ 305: 678-683.
52. Podar T & LaPorte RE (1993): Incidence of childhood diabetes did not increase in Estonia during 1980-89. Diabète et Métabolisme 19: 361-363.
53. Prior MJ, Prout T, Miller D, Ewart R, Kumar D & the ETDRS Research Group (1993): C-peptide and the classification of diabetes mellitus patients in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 6. Ann Epidemiol 3: 9-17.
54. Reichard P, Nilsson B-Y & Rosenqvist U (1993): The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304-309.
55. Retinopathy Working Party (1991): A protocol for screening for diabetic retinopathy in Europe. Diabet Med 8: 263-267.
56. Sinclair SH, Nesler C, Foxman B, Nichols CW & Gabbe S (1984): Macular edema and pregnancy in insulin-dependent diabetes. Am J Ophthalmol 97: 154-167.
57. The Diabetes Control and Complications Trial Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
58. The Diabetes Control and Complications Trial Research Group (1995): Progression of retinopathy with intensive versus conventional treatment in the The Diabetes Control and Complications Trial. Ophthalmology 102: 647-661.
59. The Diabetic Retinopathy Study Research Group (1976): Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81: 383-396.
60. Tooke JE (1995): Microvascular function in human diabetes. Diabetes 44: 721-726.
61. Tuomilehto J, Podar T, Reunanen A, Kalits I, Lounamaa R, Tuomilehto-Wolf E, Adojaan B, Neff B & LaPorte RE (1991): Comparison of incidence of IDDM in childhood between Estonia and Finland, 1980-1988. Diabetes Care 14: 982-988.
62. Waite JH & Beetham WP (1935): The visual mechanism in diabetes mellitus. N Engl J Med 212: 367-379, 429-443.
63. Wang PH, Lau J & Chalmers TC (1993): Meta-analysis of effects of intensive blood glucose control on late complications of type I diabetes. Lancet 341: 1306-1309.